Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

<p>Abstract</p> <p>Optimal conditioning therapy for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains undefined. We retrospectively compared outcomes of a consecutive series of 51 AML patients treated with oral busulfan (1 mg/kg every 6 hours for...

Full description

Bibliographic Details
Main Authors: Nishihori Taiga, Kharfan-Dabaja Mohamed A, Anasetti Claudio, Kim Jongphil, Pidala Joseph, Field Teresa, Perkins Janelle, Perez Lia, Fernandez Hugo F
Format: Article
Language:English
Published: BMC 2010-10-01
Series:Journal of Hematology & Oncology
Online Access:http://www.jhoonline.org/content/3/1/36

Internet

http://www.jhoonline.org/content/3/1/36

Similar Items